Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences.
Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences.
复制标题
回复:宿主内 HIV 2 型变异的后续研究揭示了 C2V3 序列的不连续进化。
DOI:
10.1089/08892220152644278
复制
发表时间:
2001
影响因子:
1.5
通讯作者:
Mullins,JI
中科院分区:
文献类型:
--
作者:
Gottlieb,GS;Mullins,JI
EDITOR: It is generally believed that a thorough understanding of intrapatient genetic variation and evolutionary dynamics of HIV will provide important insight into HIV/AIDS pathogenesis. Studies of HIV-1 subtype B in the MACS cohort suggest there are consistent viral evolutionary changes associated with the progression of disease and that rates of viral diversity and divergence follow a predictable pattern. 1 Before these studies there was an incomplete and confusing array of HIV-1 diversity and divergence data that was plagued by patient samples from different stages of disease, short follow-up times, and concerns of resampling errors biasing results. 2 It is unknown whether the pattern of increasing viral diversity and divergence, and the emergence of CXCR4-tropic viruses, that is observed in HIV-1 patients progressing to AIDS is occurring in patients infected with HIV-2. There have been few previous studies of intrapatient HIV-2 evolution during the course of the disease. A report by Sankale et al. 3 described the intrapatient variability of HIV-2 env V3 loop PBMC viral sequences in 5 patients and showed lower viral diversity in asymptomatic (0.6%) than in symptomatic (2.0%) patients and increasing diversity over time. They also noted that intrapatient diversity in HIV-2 was lower than that reported in HIV-1. However, it is unclear whether these observed differences were due to different virus biology, patient selection bias, or underestimation of HIV-2 diversity due to population resampling errors. 2 It is therefore with great interest that the study by Esteves et al. 4 appeared in AIDS Research and Human Retroviruses.They describe the intrahost HIV-2 evolution of the C2V3 region of gp105 over 5 years in two patients, one who was also infected with HIV-1. Interestingly, in subject D (HIV-1/2 dually infected) the HIV-2 mean genetic diversity reportedly appears to be decreasing dramatically over the course of 5 years (1992, 4.3%; 1995, 0.7%; 1997, 0.5%) whereas in subject C (HIV-2 only) the HIV-2 mean genetic diversity reportedly appears to be decreasing and then increasing (1992, 2.5%; 1995, 1.1%; 1997, 5.4%). Given what has been previously reported by Sankale et al. 3 and our own unpublished observations of HIV-2 evolution, and what is known about sequence evolution in HIV-1, we find these results puzzling. On inspection of the phylogenetic tree provided by the authors, it would appear there might be a problem with resampling bias. From subject D, 8 of the 10 sequences from 1997 appear identical, and 2 of 9 and 3 of 9 sequences from 1995 also appear identical. From subject C, 3 of the 11 sequences from 1995 also appear identical. Thus resampling error could explain the ob-